🔎 Trials Near Me

Hjem › Type 2-diabetes › Texas › Dallas

Kliniske studier for Type 2-diabetes i Dallas, TX

19 studier for Type 2-diabetes søker deltakere på steder i og rundt Dallas (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.

Offisiell studietekst (engelsk)

Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →

Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema

RekruttererFase 3
  • North Texas Endocrine Center, Dallas
Alder 18 og eldre · Alle kjønn · Oppdatert 30. sep. 2026 · NCT07817251

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

RekruttererFase 3
  • Soltero Cardiovascular Research Center, Dallas
  • North Texas Endocrine Center, Dallas
  • Southwest Family Medicine Associates, Dallas
  • og 1 flere
Alder 18 og eldre · Alle kjønn · Oppdatert 30. sep. 2026 · NCT07064473

A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar

RekruttererFase 3
  • University of Texas Southwestern Medical Center, Dallas
Alder 18 og eldre · Alle kjønn · Oppdatert 30. sep. 2026 · NCT07754461

NT-ProBNP-based Heart Failure Screening and Prevention Trial in Patients With Type 2 Diabetes: STRONG-DM Study

Rekrutterer
  • University of Texas Southwestern Medical Center, Dallas
  • Parkland Health & Hospital System (PHHS), Dallas
  • Baylor Scott and White - Health System, Dallas
Alle aldre · Alle kjønn · Oppdatert 29. sep. 2026 · NCT06593327

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

RekruttererFase 3
  • Velocity Clinical Research, Dallas, Dallas
Alder 18 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07282600

A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus

RekruttererFase 2
  • M3 Wake Research - Dallas, Dallas
  • University of Texas Southwestern Medical Center, Dallas
Alder 18 til 75 · Alle kjønn · Oppdatert 15. sep. 2026 · NCT07340320

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

RekruttererFase 3
  • Velocity Clinical Research, Dallas
Alder 18 og eldre · Alle kjønn · Oppdatert 14. sep. 2026 · NCT07351058

A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes

RekruttererFase 2
  • University of Texas Southwestern Medical Center, Dallas
Alder 18 til 75 · Alle kjønn · Oppdatert 11. sep. 2026 · NCT07415954

Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease

RekruttererFase 2
  • M3 Wake Research Dallas - Internal Medicine, Dallas
  • Revival Research Institute, LLC, Dallas
Alder 18 til 80 · Alle kjønn · Oppdatert 11. sep. 2026 · NCT07271186

Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)

RekruttererFase 2
  • Velocity Clinical Research - Dallas, Dallas
Alder 18 og eldre · Alle kjønn · Oppdatert 9. sep. 2026 · NCT07296484

A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes

RekruttererFase 2
  • Mercy Family Clinic, Dallas
  • Velocity Clinical Research, Dallas, Dallas
Alder 18 til 75 · Alle kjønn · Oppdatert 8. sep. 2026 · NCT07215559

A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus

RekruttererFase 3
  • Research Site, Dallas
Alder 18 og eldre · Alle kjønn · Oppdatert 31. aug. 2026 · NCT07662109

A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)

RekruttererFase 3
  • Research Institute of Dallas, Dallas
Alder 10 til 17 · Alle kjønn · Oppdatert 7. aug. 2026 · NCT06739122

Polypill for Prevention of Cardiomyopathy

RekruttererFase 1/2
  • UT Southwestern Medical Center, Dallas
Alder 18 til 100 · Alle kjønn · Oppdatert 4. aug. 2026 · NCT06143566

Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy

RekruttererFase 2
  • Zenos Clinical Research, Dallas
Alder 18 til 70 · Alle kjønn · Oppdatert 15. jun. 2026 · NCT07502508

HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes

RekruttererFase 2
  • Velocity Clinical Research Dallas, Dallas
Alder 18 og eldre · Alle kjønn · Oppdatert 23. apr. 2026 · NCT07546929

Assessing the Efficacy of Targeted Home Visits in the Management of Chronic Conditions

Rekrutterer
  • UT Southwestern Medical Center, Dallas
Alder 18 til 60 · Alle kjønn · Oppdatert 10. feb. 2026 · NCT05168605

Type 2-diabetes-studier i andre byer

Andre studier i Dallas

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.